Patent · US Active

Combination with albumin, in particular for treating a cartilage defect

US11065364B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

TETEC Tissue Engineering Technologies AG · DE

Inventors

Helmut Wurst · Tübingen, DE
Nils Clausen · Lörrach, DE
Nina Baldassi · Lörrach, DE

Key dates

Filing date	Aug 28, 2017
Grant date	Jul 20, 2021
Priority date	—
Expiry date	Sep 15, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2400/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A combination comprising, spatially separate from one another, a first component and a second component, where the first component comprises crosslinkable albumin and the second component comprises a polymer, wherein non-terminal monomer units of the polymer comprise at least partially, more particularly only partially, an albumin-crosslinking group. Additionally disclosed is a reaction product obtainable by means of the combination, to a medical device, to a medicinal product for innovative therapies, to a kit, to a discharge apparatus, and to a functionalized hyaluronic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.